BS
Bharti Singh
About Bharti Singh
Data last updated:
Bharti Singh is a Director at Vitaegen Biotech Private Limited (since 2009) and Director at Prangenix Therapeutics Private Limited (since 2025). The companies operate in Education & Learing. The largest current company by reported revenue is Vitaegen Biotech Private Limited at ₹4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 May 2009 | 2009 | ₹4 Lakh (FY 2025) | Active | |
| Director | 21 Jun 2025 | 2025 | Active |
Board colleagues of Bharti Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepmala Katiyar | 02612288 | Vitaegen Biotech Private Limited , Prangenix Therapeutics Private Limited | Director |
| Panch Deo Singh | 02612340 | Vitaegen Biotech Private Limited | Director |
| Shiv Prasad Katiyar | 07322531 | Vitaegen Biotech Private Limited | Director |
| Rajeev Vikram | 11166014 | Prangenix Therapeutics Private Limited | Director |
| Sushil Kumar Aggarwal | 11166015 | Prangenix Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bharti Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bharti Singh
Bharti Singh currently holds 2 directorships: Vitaegen Biotech Private Limited (Director, since 06 May 2009, revenue ₹4 Lakh (FY 2025)); Prangenix Therapeutics Private Limited (Director, since 21 Jun 2025).
Bharti Singh was first appointed on 06 May 2009 as Director at Vitaegen Biotech Private Limited. The most recent appointment on record is 21 Jun 2025 at Prangenix Therapeutics Private Limited.
The current boards of Bharti Singh's companies include Deepmala Katiyar (Vitaegen Biotech Private Limited), Panch Deo Singh (Vitaegen Biotech Private Limited), Shiv Prasad Katiyar (Vitaegen Biotech Private Limited), Rajeev Vikram (Prangenix Therapeutics Private Limited), Sushil Kumar Aggarwal (Prangenix Therapeutics Private Limited).